Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.

Researchers created a risk-assessment algorithm that shows consistent performance across datasets from US, Europe, and Asia.

Facility within MIT.nano offers equipment and capabilities for visualizing data, creating immersive environments.

Unbiased, high-throughput analysis pipeline improves utility of “minibrains” for understanding development and diseases such as Zika infection.

Applications and challenges of sensing technology have been accelerated by Covid-19.

MISTI Global Seed Funds are open for proposals after Covid pivot.

Machine learning model predicts probability that a particular urinary tract infection can be treated by specific antibiotics.

Mathematical analysis suggests that preventing large gatherings could significantly reduce Covid-19 infection rates.

United under the Sustainability Incubator Fund, researchers strategize sustainable sourcing solution for crises at the local and global level.

MIT conference illustrates technologies developed in response to the pandemic and new opportunities for AI solutions for clinical management.